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It has been reported by many authors that a  variety of thiol compounds augment 
various lymphocyte reactions in vitro, including antibody responses (1,  2), induction 
of cytotoxic T  cells in the mixed lymphocyte culture  (3,  4), and the DNA synthetic 
response  to  mitogens  (5-7).  2-Mercaptoethanol  (2-ME), 1 one  of the  most  effective 
thiols,  was  shown  to  be a  polyclonal  activator of both  T  cells  (8)  and  B  cells  (9). 
Although 2-ME is widely used as an effective additive to lymphocyte cultures to elicit 
in  vitro antibody responses,  its mechanism of action  still  remains to be elucidated, 
particularly at the molecular level. Opitz et al.  (10)  have proposed that  2-ME does 
not act directly on lymphocytes, but interacts with fetal calf serum (FCS) to convert 
its  component(s)  into  activated  form,  which  in  turn  is  directly  involved  in  the 
augmentation of the primary antibody response to sheep erythrocytes (SRBC)  (11). 
Sidman and Unanue  (12)  also demonstrated that the enhancing effect of 2-ME was 
mediated by 2-ME-activated serum factor(s) in anti-Ig antibody-induced proliferation 
of murine B  cells. The chemical nature of these  2-ME-activated factor(s), however, 
has not  been investigated in  detail.  On  the other hand,  Goodman et al.  (9,  13,  14) 
have reported that 2-ME could act directly on late-maturing, resting murine lympho- 
cytes, including both T  cells and B cells, to trigger their proliferation and differentia- 
tion. They have reported (15)  that synergistic cooperation between T  and B cells was 
involved in the activation process by 2-ME. It has been recently proposed by Hoffeld 
and  Oppenheim  (16)  that  a  major role of 2-ME  in  the  augmentation  of antibody 
response in vitro is to convert oxidized glutathione (GSSG) in the serum into reduced 
glutathione (GSH). The former compound had inhibitory effect on antibody response, 
whereas 2-ME was found to reverse its inhibition.  Thus, we have no final conclusion 
as to the mechanism of action of 2-ME.  In a  previous paper (7),  we compared the 
enhancing  activities of various thiol  compounds  and  found  that  antibody response 
was  markedly  augmented  by cysteine, which  has  higher  reduction  potential  than 
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GSH and  thus is not  able to reduce GSSG into GSH.  Moreover, both  cysteine and 
cystine enhanced  the  response  as effectively as 2-ME  if they  were  added at  higher 
concentrations  (2.5-5  mM).  When  fresh  cysteine,  but  not  cystine, was  fed  serially 
every  12  h,  the  dose-response  curve  of  the  compound  shifted  distinctly  to  lower 
concentrations.  If one  considers  that  cysteine  is  readily oxidized  to  cystine  in  the 
culture conditions  (17),  it is suggested that  lymphocytes could be activated by both 
cysteine and cystine, but  the former compound would be used more efficiently than 
the latter. These observations prompted us to investigate whether cyst (e)ine is required 
as an  essential amino  acid  in  antibody response  in  vitro  and  whether  2-ME  could 
facilitate, in  some  way,  the  utilization of cystine  that  is  contained  in  RPMI  1640 
medium  as a  cysteine source. A  preliminary report dealing with  these problems has 
been published (18). 
Materials  and  Methods 
Mice.  Female BALB/c mice were purchased from Japan Charles River Breeding Labora- 
tories (Tokyo, Japan) and were used during 10-15 wk of age. 
Chemicals and Culture Media.  The reagents used in the present experiments were obtained 
from the following sources: 2-ME and  L-cysteine hydrochloride, Tokyo Kasei, Tokyo; dithio- 
threitol  (DTT)  and  GSH,  Sigma Chemical  Co.,  St.  Louis, MO;  e-cystine dihydrochloride, 
Ishizu Seiyaku, Osaka, Japan.  RPMI  1640 medium and Eagle's minimum essential medium 
(MEM)  were purchased from Nissui Pharmaceutical Company (Tokyo). FCS (lot 31Kl101) 
was obtained from Gibco Laboratories, Grand Island Biological Company (Grand Island, NY). 
RPMI  1640  medium,  from  which  cystine and  GSH  were  omitted,  was  prepared  by using 
commercially available ingredients (amino acids, vitamins, and inorganic salts) according to 
the composition reported by Moore et al. (19). Culture medium was usually supplemented with 
penicillin G  (50/~g/ml) and streptomycin (50/tg/ml). 
Antigens and Mitogens.  SRBC stored in sterile Alsever's solution was obtained from Nishinip- 
pon Sheep Farm (Fukuyama, Japan). SRBC were washed twice with sterile saline before use. 
Dinitrophenyl (DNP)36-Ficoll was prepared by coupling ~-DNP-L-lysine (Sigma Chemical Co.) 
and Ficoll 400  (Pharmacia Fine Chemicals, Uppsala, Sweden) with cyanuric chloride (Wako 
Chemicals, Tokyo) as a  cross-linker, according to the method  by Haba and  Hamaoka (20). 
Trinitrophenylated lipopolysaccharide (TNP-LPS)  was prepared by reacting trinitrobenzene 
sulfonate  (Tokyo  Kasei, Tokyo)  with  LPS  by  the  procedure  as  described  by Jacobs  and 
Morrison (21). LPS was the phenol-water extracts ofEscherichia  coli 055 B5 (Difco Laboratories, 
Detroit, MI). Concanavalin A (Con A) was the product of E. Y. Laboratories (San Mateo, CA). 
Lymphocyte Suspension.  Dissociated spleen cells were prepared in MEM by teasing spleens on 
rough stainless mesh with spatula. This preparation was passed through stainless mesh  (40- 
mesh) to remove large debris followed by washing once with MEM and were finally suspended 
in  RPMI  1640  medium  supplemented with  10%  FCS  (RPMI-FCS)  at  an  appropriate cell 
density. When cells were cultured in cystine-free RPMI  1640 medium, the cells were washed 
before  culture  twice  with  Hank's  balanced  salts  solution  to  avoid  the  contamination  of 
eyst(e)ine. The number of viable cells were counted by trypan blue exclusion test. 
Culture of Spleen Cells  for Primary Antibody Response and Assay of Antibody-forming Cells.  Spleen 
10 ) were cultured with SRBC (2 ×  106), DNP-Ficoll (20 ng/ml), or TNP-LPS (1 ~tg/  cells (8 X  6 
ml) in 2 ml of RPMI-FCS at 37°C in a  humidified atmosphere of 5% CO2 and 95% air for 4 
d  using  24-well  multi-dish  culture  plates  (NUNC,  Kamstrup,  Denmark).  In  the  case  of 
polyclonal antibody synthesis, the same number of cells were cultured in the presence of 50 p~g/ 
ml LPS for 2 d. When cystine-free RPMI  1640  medium was used, 6  x  10  spleen cells were 
cultured  with  2  ×  l0  s  SRBC  in  1 ml  of the  medium  containing  10%  FCS  and  varying 
concentrations of cystine for 4 d as described above. Cystine concentrations were expressed as 
those of half-cystine in this paper. Antibody synthesis was assayed by enumerating the number 
of hemolytic plaque-forming cells (PFC)  by  the  method  of Jerne  and  Nordin  (22).  Lightly 
conjugated TNP-SRBC were prepared as described by Rittenberg and Pratt (23) for detecting 
anti-TNP PFC. Polyclonal antibody synthesis was assayed by using SRBC as the target. The ttlTOSttI OttMORI AND ITARU YAMAMOTO  1279 
number of direct PFC was counted in all cases. All cultures were carried out in duplicate or 
triplicate. Typical data from several  repeated experiments were presented. Standard error did 
not usually exceed 10-15% of the mean value. 
DNA Synthetic Response.  Using 96-well  microculture plates (NUNC), spleen cells (1  ×  105) 
were cultured in triplicate with Con A (2.5/zg/ml) or LPS (25/zg/ml) in 200/zl of cystine-free 
RPMI 1640 medium containing 5% FCS at 37°C for 48 h in the humidified atmosphere of 5% 
CO2  and 95%  air. Where indicated, 2-ME or varying concentrations of cystine was supple- 
mented. Cells were then radiolabeled for  18 h with 0.5/zCi of [6-3H]thymidine ([3H]TdR) (20 
Ci/mmole, Radiochemical Center Amersham, Amersham, England). The cultures were har- 
vested with automatic cell harvester (Labo Mash  101, Labo Science, Tokyo) onto glass filter 
strips.  Incorporated radioactivities were counted with liquid scintillation  counter (Aloka Model 
LSC 700), 
Uptake of 3~S-Cyst(e)ine by Murine Lymphocytes.  In this experiment, RBC were removed from 
spleen  cell  suspensions according  to  the  procedure  described  by  Mishell  (24) with  slight 
modifications. In brief, spleen cell  pellets were rapidly suspended in 9:1  mixture of 0.16  M 
NH4CI  and 0.17  M  Tris-HCl buffer (pH  7.65) at the density of 2  3 ×  10  v cells/ml and were 
kept  for  2 min at  room temperature. Cell suspensions were  then underlayed with FCS and 
centrifuged at 500 g for 5 min. The cell pellets were washed once with MEM and twice with 
Hanks' balanced salts solution at 4°C. 4-6 million RBC-depleted spleen cells were incubated 
in  1 ml  of cystine-free  RPMI  1640 medium  supplemented with  10%  FCS  and  0.1  mM 
3~S-L-cystine (as halfcystine) (0.5/~Ci, RCC Amersham) at 37°C in the humidified atmosphere 
of 5% CO2 and 95% air for the time indicated. When uptake reactions were performed for <1 
h, the medium was buffered with 20 mM Hepes (Sigma Chemical Co.)  (pH 7.2) and incubated 
in air. When cysteine uptake was investigated, the mixture of 1 mM cysteine and 35S-cystine 
(5/~Ci/ml), which was kept at room temperature for 30 min in the presence of 2 mM DTF, was 
used as 3~S-cysteine preparation. The uptake reactions were terminated by adding 4 ml of cold 
phosphate-buffered saline (PBS)  followed  by centrifugation at  1,000 g for 2 min. The pellets 
were again washed with 4 ml of cold PBS and finally suspended in 1 ml of PBS. Incorporated 
radioactivities were counted in ACS II scintillation  cocktail (Radiochemical Center Amersham) 
using liquid scintillation counter (Aloka, LSC 700). 
Enrichment of T and B Cells.  RBC-depleted murine spleen cells (2 ×  107) were suspended in 
1 ml of MEM buffered with  10 mM Hepes (pH  7.2) (MEM-Hepes) containing monoclonal 
anti-Thy-1,2 (1:500, Olac 1976, Blackthorn, England) or anti-Ig (1:3) and were kept below 4°C 
for 30 rain. Anti-Ig were prepared in our laboratory by repeated immunization  of rabbits with 
purified BALB/c IgG fraction. After centrifugation and washing once with MEM-Hepes, the 
cells  were  resuspended  in  0.7  ml  MEM-Hepes.  Upon  addition  of  0.1  ml  of  guinea  pig 
complement, the cells were incubated at 37°C for 30 min with occasional stirring, centrifuged, 
washed three times with MEM, and finally suspended in an appropriate volume of the culture 
medium. The treatment with anti-Thy-1,2 killed 40-50% of spleen lymphocytes and reduced 
Con A-induced [3H]TdR uptake by 85-95% without significantly  affecting the response to LPS. 
On the other hand, anti-Ig treatment resulted in 50-55% killing and decreased LPS-induced 
[3H]TdR  uptake by 80-85%,  whereas  Con A  response was  not significantly altered.  T  cell 
enrichment was  also  performed  by  passing spleen  cells  through  a  nylon wool  column as 
described by Julius et al. (25). 
Depletion of Adherent Cells.  Spleen cells  from  which  RBC  were  removed previously were 
depleted of adherent cells by passage over Sephadex G-10 column (Pharmacia Fine Chemicals) 
as reported by Ly and Mishell (26) with some modifications. Briefly, spleen cell suspension in 
MEM-Hepes containing 5% FCS (1 ×  10  s cells/ml) was applied to Sephadex G-10 column (2 
ml bed vol/108 cells) which was previously equilibrated with the same medium. Adherent cell- 
depleted spleen cells were  recovered by eluting the column with MEM-Hepes containing 5% 
FCS (average recovery,  40%). 
Results 
Augmentation  of Primary Antibody  Response by 2-ME and Cysteine.  Table I  shows that 
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TABLE  I 
Effect of 2-ME on the Antibody Response to SRBC, DNP-Ficoll, and TNP-LPS 
2-ME 
(1  X 10  .5 M)* 
Anti-SRBC PFC/cuhure:~  Ant i-TNP-PFC/cult  ure~ 
No antigen  SRBC  No antigen  DNP-Ficoll  TNP-LPS 
-  240 +  90  660 + 60  230 +- 30  400 + 40  510 +  90 
+  300+30  2295+315  470+  110  1830+270  2040+  140 
* Spleen cells (8 X  lO  6) were cultured with various antigens in the presence or absence of 1 ×  10  -5 M 2-ME 
as described  in Materials and Methods. 
:~ Mean +  SE. 
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Ftc;.  1.  Effect of cysteine or cystine concentrations on the antibody response to SRBC in vitro in 
the presence  or absence  of 2-ME.  Spleen  cells (6 x  106) were cultured with 2 X  10  6 SRBC in  1 ml 
of cystine-free  RPMI 1640 medium containing 10% FCS in the presence of the indicated amount of 
cysteine  or half-cystine  for 4 d.  Where indicated,  fresh solution  of cysteine  or cystine  was added 
serially every 12 h eight times. In this case, the concentrations indicate the total amount of cysteine 
or half+cystine after the final  addition.  (A)  (O) cystine,  (0)  cystine  added serially  every 12 h,  (ZX) 
cysteine,  (A) cysteine added serially every 12 h. (B) ((D) cystine, (O) cystine plus 2-ME (1 X 10  -'~ M). 
enhancement  of the  primary  antibody  responses  in  vitro to  three  different  antigens 
(SRBC,  DNP-FicolI,  and  TNP-LPS).  The  magnitude  of enhancement  varied  from 
two- to fivefold depending on the lots of FCS and  the spleen cell pools used.  We have 
tested  various  thiol compounds  for their capacity  to  augment  the  antibody  response 
in  vitro,  and  have  found  that  cysteine  could  also  enhance  the  response  (7,  18). 
Although  data  are  not  shown  here,  cysteine  was  as  effective as  2-ME  (1  X  10 -'~ M) 
when  it was added  at  5  mM  at  the start  of the culture. 
Requirement  of Cyst(e)ine in Antibody Response.  Cyst(e)ine is known  to be an essential 
amino acid in many  mammalian  cell lines (27).  RPMI  1640 medium  contains cystine 
(65 mg/liter)  and GSH  (1  mg/liter). The medium,  devoid of cystine, was prepared  to 
examine  whether  the  amino  acid  is required  as  a  nutrient  in  the  antibody  response. 
In the experiment  of Fig.  1 A, the effect of increasing concentrations  of cyst(e)ine on 
the  antibody  response  to  SRBC  was  examined  by  using  the  cystine-free  culture 
medium.  It  was  shown  that  the  immune  response  was  not  elicited  unless  cyst(e)ine 
was  supplemented  to  the  medium.  Omission  of GSH  did  not  significantly  affect  the 
response,  and  GSH  (1  nag/liter)  could elicit  no  response  in  the absence  of cystine, as 
reported  previously (18). Therefore, GSH  was usually supplemented  when the follow- 
ing  experiments  were  performed  in  cystine-free  conditions.  The  effect  of cyst(e)ine 
and  GSH  that  would  contaminate  from  RBC  and  FCS  appeared  to  be  negligible, ItITOSttl  OttMORI  AND  ITARU  YAMAMOTO  1281 
because whole splenocyte suspensions responded to the antigen absolutely depending 
on exogenously added  cyst(e)ine  (Fig.  1A).  These observations clearly showed  that 
cyst(e)ine is  an essential  nutrient  in  the  antibody response of murine  lymphocytes. 
The  PFC  response  reached  maximum  with  2.5-5.0  mM  cysteine  or  half-cystine. 
Interestingly, the dose-response curve of cysteine, but not of cystine shifted distinctly 
to lower concentrations  when  fresh  solutions  of these amino acids were fed serially 
eight times, every 12 h. We confirmed that cysteine (0.1-2.5 mM) was readily oxidized 
to cystine under our culture conditions as reported by Toohey (17).  Thus, it is likely 
that  lymphocytes could  use  cysteine  more efficiently than  cystine  for eliciting  the 
antibody response. On the other hand, the dose-response curve of cystine was shifted 
to lower concentrations by approximately one order of magnitude (Fig.  1 B). It should 
be noted that  2-ME did  not  augment the response when  half cystine was absent  or 
when an optimal concentration of half cystine (2.5  mM) was present. Namely, it only 
enhanced  the response when suboptimal doses of cystine were present in the culture 
medium.  It  was demonstrated  that  2-ME  did  increase significantly the  viability of 
lymphocytes even in the absence of cystine. The enhancing effect of 2-ME on antibody 
response, however, could  not  be explained  only by the nonspecific improvement of 
cell  viability,  because similar shift  of dose-response curve was seen  when  the  data 
were plotted as the number of PFC/106 viable cells as shown in Fig. 2. Similar results 
were obtained when DNP-Ficoll, a  thymus-independent antigen, was used  (data not 
shown). 
Cystine Requirement in DNA Synthetic Response to Mitogens and Polyclonal Antibody Synthe- 
sis.  Data  in  the  previous  section  showed  that  spleen  cells  as  a  whole  required 
cyst(e)ine for developing antibody-forming cells. To investigate the role of cystine in 
the proliferation and differentiation of T  and B cells separately, cystine requirement 
was examined in the DNA synthetic responses to T  cell-specific mitogen (Con A) and 
B cell-specific mitogen (LPS). As illustrated in Fig. 3 A and B, both responses to Con 
A  and  LPS were completely dependent  on exogenously added cystine, and reached 
maximum with  1-2.5 mM half-cystine. The addition of 1 x  10 -5 M  2-ME resulted in 
the shifting of the dose-response curves to lower concentrations, as in the case of the 
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Fro,  2.  Effect ofcystine concentrations on the antibody response to SRBC in vitro and the viability 
of lymphocytes in the presence or absence of 2-ME.  Spleen cells  (6 ×  106) were cultured with 2 × 
106 SRBC in  1 ml of cystine-free RPMI  1640  medium containing  10% FCS and varying concentra- 
tions of half-cystine in the presence (O) or absence (O) of 1 X  10 -'~ M  2-ME for 4 d. (  ) antibody 
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FIG.  3.  Effect ofcystine concentrations on the DNA synthetic response to mitogens in the presence 
or absence  of 2-ME. Spleen cells (1  X 10  n) were cultured for 48 h with Con A (2.5 #g/ml) or LPS 
(25  #g/ml)  in  0.2  ml  of cystine-free  RPMI  1640 medium  containing  5%  FCS  and  varying 
concentrations of half-c~stine  in the presence  (I)  or absence  (O) of 1 X  10  -~ M  2-ME. The cells 
were then pulsed with [ H]TdR (0.5/~Ci/well)  for 18 h. 
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F[c.  4.  Effect  of cystine  concentrations on the polyclonal antibody response  induced by LPS in 
the presence  or absence of 2-ME. Spleen cells (8 ×  l0  s) were cultured with 50 #g/ml LPS in  1 ml 
of cystine-free RPMI 1640 medium containing 10% FCS and varying concentrations of half-cystine 
in the presence  (0) or absence  (O) of I X 10  -s M 2-ME. Polyclonal  antibody response was assayed 
as the number of anti-SRBC PFC. 
antibody  response.  More  pronounced  stimulation  by  2-ME  was  observed  in  the 
proliferation of B  cells than  in that  of T  cells.  Polyclonal antibody  synthesis  induced 
by  LPS  was  similarly  shown  to  require  cystine  as  demonstrated  in  Fig.  4.  2-ME 
augmented  the response particularly when suboptimal  doses of cystine were added  to 
the  culture  medium.  The  characteristic  feature  of  DNA  synthetic  response  and 
polyclonal antibody  response was that  these responses were significantly elicited with 
0.05-0.1  mM  half cystine in contrast  to antibody response, which did not occur with 
this level of cystine. The results described thus far clearly demonstrated  that cyst(e)ine 
is  an  essential  amino  acid  in  the  proliferation  and  differentiation  of lymphocytes. 
Commercially  available RPMI  1640  usually contains  -0.41  mM  half-cystine, which 
was  shown  to  be a  suboptimal  level for maximal  response  to antigens  and  mitogens 
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Stimulation of 35S-Cystine Uptake by 2-ME.  The above data suggested that lympho- 
cytes  would  use  cysteine  more  efficiently  than  cystine,  the  use  of which,  however, 
might  be stimulated  by 2-ME.  The  following experiments  using ~S-cyst(e)ine  were 
carried out to directly prove these speculations. When RBC-depleted  murine spleen 
cells  were  incubated  with  0.1  mM  s~s-half-cystine  or  ~S-cysteine,  cysteine  was 
incorporated into the cells five to six times as rapidly as cystine (Fig. 5 A). Addition 
of 1 X  10 -5 M  2-ME resulted in ~2.5-fold  acceleration  of ~S-cystine uptake. When 
the  cells  were  incubated  for  30  min  in  this  condition,  ~30%  of the  incorporated 
radioactivity was found in trichloroacetic acid-precipitable fraction. 2-ME stimulation 
was  still  observed  when  the incubations were  prolonged up to  24 h  (Fig.  5 B).  We 
confirmed  that  2-ME  had  no  effect  on  the  viability  of lymphocytes  during  these 
incubation periods. Although data were not presented, omission of FCS did not affect 
the  rate  of  2-ME-stimulation  of  cystine  uptake.  Fig.  6  illustrates  the  correlation 
between cystine concentrations in the medium and the amount of incorporated cystine 
in the presence or absence of 2-ME. Cystine added at 2.5 mM (as half-cystine) caused 










Fxo. 5.  Effect  of  2-ME  on  the  rate  of cystine  incorporation  into  murine  lymphocytes.  RBC- 
depleted spleen cells (6 X  106) were incubated at 37°C for the time indicated in  1 ml of cystine-free 
RPMI  1640 medium supplemented with 10% FCS and 0.1 mM a~S-half-cystine or ~S-cysteine  (0.5 
p,  Ci).  (A)  Medium  buffered  with 20 mM Hepes (pH  7.2)  and incubations  performed  in  air.  (B) 
Reaction  mixture incubated without adding Hepes in the humidified atmosphere of 5% CO2 and 
95% air.  (O)  3SS-cystine,  (0) 3SS-cystine plus 2-ME (1  X  10  -~ M), (A) 35S-cysteine  (in the presence 
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Fio.  6.  Effect  of cystine  concentrations  on  its  incorporation  into  murine  lymphocytes  in  the 
presence  (0)  or absence  (O)  of 2-ME.  RBC-depleted  spleen  cells  (5  X  106) were  incubated  with 
35  increasing concentrations of  S-half-cystine in  1 ml ofcystine-free RPMI  1640 medium containing 
10% FCS and 20 mM Hepes (pH  7.2) at 37°C for 30 min. Where indicated,  1 X  10  -s M  2-ME was 
added to the medium. 1284  MODE  OF  ACTION  OF"  2-MERCAPTOETHANOL 
a  significant intracellular accumulation  of the amino  acid that was approximately  the 
same as that when  0.5 mM  half-cystine was present together with  1 x  10  -5 M  2-ME. 
Similar  stimulation  of cystine  uptake  by  2-ME  was  observed  both  in  T  and  B  cell- 
enriched lymphocytes as shown in Fig.  7. The rate of enhancement  was approximately 
the same in both  lymphocyte  fractions.  Depletion  of adherent  cells did not  affect  the 
enhancement  by  2-ME.  Fig.  8  shows  the  comparison  between  the  effects  of 2-ME 
concentrations  on antibody  response and  on aSS-cystine uptake  in RPMI-FCS,  which 
contains  0.37  mM  half-cystine.  A  close  correlation  was  observed  between  these  two 
dose-response  profiles,  thus suggesting that  a  major  role of 2-ME  in  augmenting  the 
antibody  response would  be to facilitate the utilization of cystine by lymphocytes. 
1.1  v 
,  0.5 
0 
Exot,  1 
CONTROL  B CELL 
1,01'5[  Expt'  2 
T CELL  CONTROL  T  CELL  Mph  (-) 
(Antl-lg)  (N.  W,)  (G-IO) 
Fro.  7.  Stimulation of cystine uptake in the presence ([])  and absence (m) of 2-ME in T  cell- 
enriched, B cell-enriched and adherent  cell-depleted murine lymphocytes.  RBC-depleted spleen 
cells were enriched for T cells or B cells by the treatment with anti-Ig or anti-Thy- 1,2 in the presence 
of guinea pig complement, respectively.  In  experiment  2,  T  cell-enrichment was  performed  by 
utilizing nylon wool column (N.W.).  Adherent cell-depleted lymphocytes (Mph-) were prepared by 
passing spleen cells  through Sephadex G-10 column. These lymphocytes preparations (6  ×  1061 
were incubated with 0.1 mM aSS-half cystine (0.5 ,uCi) in 1 ml of Hepes-buffered cystine-free RPMI 
1640 medium containing 10% FCS at  37°C  for 30 rain. Where indicated, 1 X  10 -'~ M  2-ME was 
added to the medium. 
× 
u 
0  10  .6  10  -5  10  -4 
2-ME  (MI 
q 
1 
i  i  i 
10-6  10-5  I0-4 
2-ME  (M) 
Flc,. 8.  Dose-response  profiles  of 2-ME in the enhancement of the antibody response in vitro and 
cystine uptake in murine lymphocytes. (A) Effect of 2-ME concentrations on the antibody response 
to SRBC in vitro. Spleen cells (8 X  1061 were cultured with 2 X  l0  s SRBC in 2 ml of RPMI-FCS 
in the presence of varying concentrations of 2-ME for 4 d. (B) Effect of 2-ME concentrations on aSS- 
cystine uptake by murine lymphocytes. RBC-depleted spleen cells (5 ×  1061 were incubated in I ml 
of RPMI-FCS containing a'~S-cystioe (2 #Ci) for 60 rain at 37°C in the humidified atmosphere of 
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Discussion 
2-ME  could  augment  primary antibody  responses in  vitro not  only to  SRBC  (a 
thymus-dependent antigen) but also to DNP-Ficoll and TNP-LPS (thymus-independ- 
ent antigens). It has been reported that macrophages and B cells are involved in the 
immune response to TNP-Ficoll  (28). On the other hand, the response to TNP-LPS 
requires neither macrophages nor T  cells (29).  We confirmed that depletion of either 
adherent cells or T  cells from murine spleen cells did not affect the augmentation of 
the response to TNP-LPS by 2-ME. Therefore, B cells would be the target of 2-ME 
action at least in this case. On the other hand, Chen and Hirsch (30)  and Lemke and 
Opitz (11)  have proposed that 2-ME could substitute for the role of macrophages in 
the  primary antibody response to  SRBC.  They removed macrophages from spleen 
cells by glass adherence (30) or carbonyl iron treatment (11).  Other authors, however, 
have demonstrated that the response to SRBC  (26)  or TNP-Ficoll (28)  was dramati- 
cally  abrogated  even  in  the  presence  of 2-ME  when  spleen  cells  were  depleted  of 
macrophages by passage through Sephadex G-10 column. We also confirmed that 2- 
ME could not substitute for the function of macrophages in Sephadex G-10-treated 
spleen cells. These findings indicated  that  2-ME could not totally substitute  for the 
role of macrophages, but rather suggested that a  class of adherent cells which could 
not be removed by glass adherence or carbonyl iron treatment but could be depleted 
by  Sephadex  G-10  column  might  be  involved  in  supporting  antibody  response  as 
accessory cells in the presence of 2-ME. 
Eagle et  al.  (27)  have reported  that  a  number of mammalian cell  lines  require 
cyst(e)ine  for  their  growth  because  these  cells  are  devoid  of cystathionase,  a  key 
enzyme for the  biosynthesis  of cysteine  from methionine.  Our present  experiments 
clearly  show  that  cyst(e)ine  is  an  essential  amino  acid  in  the  proliferation  and 
differentiation of both T  cells and B cells because the following lymphocyte reactions 
were absolutely dependent on cyst(e)ine in the culture medium: (a) antibody responses 
to  both  thymus-dependent  and  thymus-independent  antigens,  (b)  proliferative  re- 
sponse  to  Con  A  or  LPS,  and  (c)  polyclonal  antibody  synthesis  induced  by  LPS. 
Cyst(e)ine could not be replaced by 1 mM methionine, indicating that there would 
be some deletions on the metabolic pathway from methionine to cysteine in murine 
lymphocytes.  Commercially  available  RPMI  1640  contains  0.41  mM  half-cystine, 
which is a suboptimal dose judging from the dose-response curve of cyst(e)ine in Fig. 
1-3.  At  least  2.5  mM  half-cystine  was  necessary  for  eliciting  maximal  antibody 
response. 2-ME only shifted the dose-response curve ofcystine in the antibody response 
(Fig.  1 B). It could not elicit the antibody response in the absence of cystine, nor did 
it enhance the maximal response when 2.5 mM half-cystine was present. These results 
suggested  that  2-ME  would  enhance  antibody  response  through  stimulating  the 
uptake of cystine contained  in  RPMI  1640  medium at a  suboptimal concentration. 
This was clearly demonstrated by the experiments using 35S-cystine (Fig.  5,  6). The 
augmentation  by 2-ME  of the  antibody response was not  solely due  to nonspecific 
increase in the viability of whole spleen  lymphocytes as shown in Fig.  2,  but  rather 
would be attributable to the stimulated expansion of specific clones of lymphocytes. 
It appears that  the stimulation  of cystine uptake by 2-ME is not  only due to the 
fact that  2-ME reduces cystine to liberate cysteine, which was shown to be incorpo- 
rated  more  rapidly.  Free  thiol  groups  became  undetectable  within  2  h  after  the 
addition  of 1 ×  10  -4  M  2-ME to the culture  medium  (data not  shown),  but  2-ME 1286  MODE OF  ACTION OF  2-MERCAPTOETHANOL 
enhancement  of cystine uptake could still be observed during 8-24 h  of incubation. 
We found that  a  major reaction product  between  2-ME and cystine was the mixed 
disulfide after free thiol group had disappeared.  Moreover, it was demonstrated that 
the mixed disulfide  itself was incorporated  ~80% as rapidly as cysteine into murine 
lymphocytes and was readily metabolized  to cysteine and GSH. The detailed  data 
will be presented elsewhere  (H. Ohmori and I. Yamamoto, manuscript  in  prepara- 
tion). 
Broome and Jeng  (5)  have reported that the growth rate of L  1210,  a  lymphoma 
cell line, was accelerated by various sulfide and disulfide compounds including 2-ME. 
It was also reported that the cell line could grow well in the presence of macrophages 
(31)  or  fibroblasts  (32).  Bannai  and  Ishii  (33)  have  found  that  thiot  compounds, 
including cysteine, were continuously secreted from fibroblasts. While our work was 
in  progress,  a  mechanism  of action  of 2-ME  similar  to  that  presented  above was 
reported  concerning  the  growth  stimulation  of L  1210  by  2-ME  (34,  35).  It  was 
demonstrated that a 2-ME dependent line of L  1210 incorporated cystine very slowly 
but the rate was markedly accelerated by 2-ME, whereas a 2-ME-independent variant 
showed an efficient uptake of cystine which was no longer enhanced by 2-ME (34).  It 
was also reported  that  freshly isolated  human  leukocytes incorporated  cystine only 
one-tenth as rapidly as cysteine (36).  It is likely that such a  low efficiency of cystine 
uptake would be common to lymphoid cells. 
2-ME-dependent  enhancement  of cystine uptake was not  mediated by FCS com- 
ponents,  because similar stimulation  was observed when  FCS was either present  or 
absent in the medium (unpublished data). Opitz et al. (10,  11) have reported that the 
incubation of FCS with 2-ME followed by lyophilization to remove free 2-ME resulted 
in the formation of activated serum factor(s) that could support antibody response as 
effectively as 2-ME added directly to the culture medium. We have obtained several 
lines of evidence indicating that the activation of FCS by 2-ME is due to the carrying 
over of 2-ME bound  to serum proteins through  disulfide bonds. It was also demon- 
strated that this protein-bound 2-ME could be effective for stimulating cystine uptake 
(H. Ohmori and I. Yamamoto, manuscript in preparation). 
Hoffeld and Oppenheim (16) have reported that 2-ME-enhancement of the primary 
antibody response is mediated by its action on GSH in the serum. Our data indicated 
that  cyst(e)ine  at  2.5-5  mM  augmented  the  response  as  effectively as  2-ME  The 
reduction  potential  of cysteine  (-0.21  V)  is  higher  than  GSH  (-0.24  V).  Thus, 
cysteine  is  unable  to  reduce  GSSG  into  GSH.  On  the  contrary,  it  was  found  that 
oxidation  of GSH was  accelerated  catalytically  in  the  presence of cystine which  is 
readily formed from cysteine (unpublished data). We observed that antibody response 
was  elicited  when  GSH  (1  mM)  was  supplemented  to  cystine-free  RPMI  1640 
medium, thus  indicating  that  GSH could be a  source of cysteine. As in  the case of 
cystine,  2-ME augmented antibody response induced  by suboptimal concentrations 
of GSH  (unpublished  data).  Therefore,  it  is  likely  that  2-ME  would  increase  the 
intracellular  levels of GSH  and  cysteine  by accelerating  the  uptake  of these  com- 
pounds,  thus offering the more favourable conditions  for lymphocytes to proliferate 
and  differentiate.  Our  experiments  using  cystine-  and  GSH-free  culture  medium 
indicated  that  exogenously  added  GSH  was  not  required  for  eliciting  antibody 
response if cystine was present  (18).  However, particular roles of GSH contained  in HITOSHI OHMORI AND ITARU YAMAMOTO  1287 
the serum in supporting the antibody response, as proposed by Hoffeld and Oppen- 
heim (16, 37) cannot be ruled out. 
It has been reported by Shiigi and Mishell (38) that high antibody responses were 
elicited in  the absence of 2-ME when particular lots of FCS  (supportive lots)  were 
used.  They have demonstrated  that  such  lots of FCS were often contaminated  by 
gram-negative psychrophilic microorganisms that conditioned the culture medium to 
produce adjuvant and mitogenic activities (38,  39). We compared the dose-response 
curves of cystine in antibody responses when the culture medium was supplemented 
with a  "good" and a  "deficient" lot of FCS. We observed no significant differences 
between them, thus indicating that good lots of FCS would not support the response 
through facilitating cystine uptake (unpublished result). 
Stimulation  of cystine  uptake  would  not  be  a  sole  mode of action  of 2-ME  in 
augmenting antibody responses in  vitro. It  has been observed (40,  41)  that  human 
fibroblasts fell into the deficiency of intracellular glutathione and readily started to 
die due to oxidative damages after the cells were transferred into cystine-free medium. 
These authors have reported that  various antioxidants, including thiol compounds, 
were effective in  preventing the cells  from being necrotic under cystine-deficiency. 
Our data also showed that 2-ME could significantly improve the viability of murine 
lymphocytes when the cells were cultured in cystine-free conditions (Fig. 2). Therefore, 
such a  function of 2-ME  (perhaps as an antioxidant) would be responsible, in part, 
for the augmentation of antibody responses as recently reported by Hoffeld (42). The 
present  paper  demonstrated  that  cystine  was  a  limiting  nutrient  when  murine 
lymphocytes were cultured in RPMI-FCS, and suggested that every factor affecting 
cystine utilization would modify antibody responses in vitro. 
Summary 
The mechanism of augmentation of the primary antibody response in vitro by 2- 
mercaptoethanol (2-ME) was investigated. By using cystine-free RPMI 1640 medium, 
it was demonstrated that cyst(e)ine was absolutely required for eliciting the following 
murine lymphocyte reactions: antibody response to sheep erythrocytes, proliferative 
response  to concanavalin A  or lipopolysaccharide  (LPS), and  polyclonal antibody 
response induced by LPS. The maximal antibody response was attained with 2.5-5 
mM cysteine or half-cystine. The serial feeding of fresh cysteine markedly amplified 
its capacity to support  antibody response particularly when cysteine concentration 
was suboptimal. Such an effect was not observed in the serial addition of cystine. On 
the other hand, the dose-response curve of cystine was dramatically shifted to lower 
concentrations by the addition of 2-ME  (1  ×  10  -5 M), which alone could not elicit 
the antibody response in the absence ofcystine, nor could it augment furthermore the 
maximal  response induced by 2.5  mM  half-cystine. Commercially available RPMI 
1640  medium  contains  0.41  mM  half-cystine,  which  proved  to  be  a  suboptimal 
concentration for eliciting the maximal  response. 35S-cystine  was  incorporated into 
murine lymphocytes five to six times more slowly than 35S-cysteine. The rate ofcystine 
uptake, however, was accelerated by 2.5-fold in the presence of 1 ×  10  -5 M  2-ME. A 
close correlation was observed between dose-response profiles of 2-ME in augmenting 
the antibody response and the stimulation of cystine uptake.  These results strongly 
suggest that one of the roles of 2-ME in augmenting the antibody response in vitro is 1288  MODE  OF ACTION OF  2-MERCAPTOETHANOL 
to facilitate the use of cystine contained in RPMI  1640 medium only at a  suboptimal 
concentration. 
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